Enhanced Mycophenolic Acid Production by Penicillium brevicompactum with Enzymatically Hydrolyzed Casein
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32799
Enhanced Mycophenolic Acid Production by Penicillium brevicompactum with Enzymatically Hydrolyzed Casein

Authors: F. Ardestani, S. S. A. Fatemi, B. Yakhchali

Abstract:

Mycophenolic acid (MPA) is a secondary metabolite produced by Penicillium brevicompactum, which has antibiotic and immunosuppressive properties. In this study, the first, mycophenolic acid was produced in a fermentation process by Penicillium brevicompactum MUCL 19011 in shake flask using a base medium. The maximum MPA production, product yield and productivity of process were 1.379 g/L, 18.6 mg/g glucose and 4.9 mg/L. h, respectively. Also the glucose consumption, biomass and MPA production profiles were investigated during batch cultivation. Obtained results showed that MPA production starts approximately after 180 hours and reaches to a maximum at 280 h. In the next step, the effects of some various concentrations of enzymatically hydrolyzed casein on MPA production were evaluated. Maximum MPA production, product yield and productivity as 3.63 g/L, 49 mg/g glucose and 12.96 mg/L.h, respectively were obtained with using 30 g/L enzymatically hydrolyzed casein in culture medium. These values show an enhanced MPA production, product yield and process productivity pr as 116.8%, 132.8% and 163.2%, respectively.

Keywords: Penicillium brevicompactum, Enzymatically hydrolyzed casein, Mycophenolic acid, Submerged culture

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1085459

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 2323

References:


[1] T.Rainiene, Immunosuppression in the past and today, Acta Medica Lituanica. 2005, pp. 10-17.
[2] S. Tian, P. Mele, F. Halloran, The use of mycophenolate mofetil in transplant recipients, J. Immunopharma. 2000, pp. 215-245.
[3] A.Charlotte, J. Hans Charleston, Mycophenolic acid inhibits inosine 5- monophosphate dehydrogenase and suppresses immunoglobulin and cytokine production of B cells, Int. Immunopharma. 2003, pp. 31-37.
[4] C. D. BARTMAN, et al, Mycophenolic Acid Production by Penicillium brevicompactum on Solid Media, Appl. Environ. Microbiol. 1981, pp. 729-736.
[5] D. L. Doerfler, C. D. Bartman, L. M. Campbell, Mycophenolic acid production by Penicillium brevicompactum in two media. Can. J. Microbiol. 1979, pp. 940-943.
[6] Vinokurova, NG., Ivanushkina, NE., Kochkina, GA., Arinbasarov, MU., Ozer-skaya, SM., Production of mycophenolic acid by fungi of the genus Penicillium link, Appl Biochem Microbiol., 2005, Pp 83-86.
[7] Bartman, C. D.; Doerfler, D. L.; Bird, B. A.; Remaley, A. T.; Peace, J. N.; Campbell, I. M. mycophenolic acid production by Penicillium brevicompactum on solid media, App. Environ. Microb, 1981, Pp 729- 736. .
[8] A. Sircar, et al. Manufacture and purification of mycophenolic acid, United States Patent. PCT No.: PCT/INOO/00017 , 2003.
[9] O. Puel, S. Tadrist, et al, Byssochlamys nivea as a source of mycophenolic acid, Appl. Environ. Microbiol. 2005, pp. 550-553.
[10] P. Lafont, J. Debeaupuis, M. Gaillardia, J. Payen, Production of mycophenolic acid by Penicillium roqueforti strains, Appl. Environ. Microbiol. 1978, pp. 365-368.
[11] Z. Xu, S. Yang, Production of mycophenolic acid by Penicillium brevicompactum immobilized in a rotating fibrous-bed bioreactor, Enzyme Microb. Technol. 2007, pp. 623-628.
[12] Alania, F.; Grove, J. A.; Anderson, W. A.; Young , M. M. Mycophenolic acid production in solid-state fermentation using a packed-bed bioreactor, Biochem. Eng, 2009, 44, 106-110.
[13] Bahrami, G.; Mohammadi, B. An isocratic high performance liquid chromatographic method for quantification of mycophenolic acid and its glucuronide metabolite in human serum using liquid liquid extraction: Application to human pharmacokinetic studies, Clinica Chimica Acta, 2006, 370, Pp 185-190.
[14] A. Fawzy, A. Elbarbry, Simple high performance liquid chromatographic assay for mycophenolic acid in renal transplant patients, J. Pharma. Biomedica. Ana. 2007, pp. 788-792
[15] www.brenda.com
[16] Masurekar, P. S., Demain, A. Insensitivity of homocitrate synthase in extracts of Penicillium chyrosogenum to feedback inhibition by lysine, Appl. Microbiol, 1974, 28 (2), Pp 265-270
[17] C. T. Bedford, C. Fairlipe, Sequence Studies in Biosynthesis; Mycophenolic Acid, Chem. Com. 1971, pp. 323-324.
[18] W. L. Muth, I. Nash, Biosynthesis of mycophenolic acid: purification and characterization of S-adenosyl-L-methionine: demethylmycophenolic acid o-methyltransferase, Antimicrob. Chemo. 1975, pp. 321-327.
[19] H. Ozaki, M. Ishihara, T. Kida, S. Yamanaka, H. Shibai, Mycophenolic acid production by drug-resistant and methionine or glutamic-acid requiring mutants of Penicillium brevicopactum, Agric Biol Chem. 1987, pp. 2509-2514.
[20] F. Ardestani, S.A. Fatemi, B. Yakhchali, M. Hosseyni, G. Najafpour, The effects of methionine and acetate concentrations on mycophenolic acid production by Penicillium bervicompactum MUCL 19011 in submerged culture, Int. J. of Natural Sciences and Engineering, 2009 (2:2), pp. 83-86.
[21] Karaffa, L.; Sandor, E.; Kozma, J.; Szentirmai, A. Methionine enhances sugar consumption, fragmentation, vacuolation and cephalosporin-C production in Acremonium chrysogenum, Process Biochem, 1997, 32 (6), 495-499.